Nipro - Company Profile
Nipro Medical Corporation specializes in custom medical manufacturing solutions including medical-surgical, renal, and vascular access devices. Headquartered in Miami, Florida, it employs over 10,000 people.
Nipro Medical Corporation was established in 1996 in Miami, Florida. In the beginning, its business model was based mainly on OEM (Original Equipment Manufacturer) contracts, manufacturing quality products for top medical corporations. Today, they continue to provide custom product design and manufacturing expertise to other medical suppliers but have since expanded our portfolio to include a complete line of products under the Nipro brand. In 2014, the North American sales and marketing office was relocated to Bridgewater, New Jersey.
Nipro Medical Corporation is a subsidiary of Nipro Corporation which was established in 1954, employs over 20,000 team members, and specializes in medical, pharmaceutical and glass products. Nipro was founded in 1947 as a light bulb recycling business. In 1954, Nihon Glass Shoji Co. Ltd. (currently Nipro Corporation) was established and began marketing glass tubes for ampules. Its products included not only medical glass but also small light bulbs and glass for thermos bottles. The company also entered the supermarket business (later Nissho Store).
REVENUE AND CAPITAL
Nipro Medical Corporation had a revenue of $2.1 billion USD for the nine months period ended December 31, 2017, with Nipro Corporation at $2.7 billion USD, respectively. A separate market capital of Nipro Medical Corporation was not found, but the market capital of the Nipro Corporation is $2.4 billion USD.
The company's website, annual reports, as well as other credible websites were very limited on marketing leadership details, events program information and partnerships. It seems that most of such data is not publicly available, but what is available has been provided. In general, marketing strategies and specificas are not publicly disclosed even by public companies. This is something that is not required by any regulations to disclose and is therefore reliant on media mentions and public interviews. As there are few of those available for Nipro, we have endeavored to provide all information we were able to unearth during our research.
SALES AND MARKETING LEADERSHIP
Mitsutaka Ueda serves as Deputy General Manager of Medical Technology, Division for Planning, Development & Marketing and Director of Nipro Corporation and is responsible for its Domestic Division. Prior to this position, Mr. Ueda served as Deputy Chief Director of Product Development and Sales in Domestic Business Unit in the company.
Mr. Yasushi Kutsukawa serves as Medical Sales General Manager of Domestic Business Department and Director at Nipro Corporation and is responsible for its Domestic Division. Prior to this position, Mr. Kutsukawa served as "Director of Central Area Sales and Deputy Chief Director of Sales in Domestic Business Unit in the company, and worked for a company that was merged with the company."
Belgian Alzheimer specialist ADx NeuroSciences signed a R&D
agreement with Nipro in 2016, giving Nipro access to forefront the synergistic collaborative R&D work in Alzheimer’s disease, accelerating the development of next-generation Point of Care in vitro diagnostic (IVD) products and Alzheimer's disease diagnostics.
Nipro Corporation and Transonic Systems Inc. (New York, USA) announced the formation of a Joint Venture (JV) under which Nipro will receive exclusive marketing and sales rights for all non-OEM Transonic products in Japan.
Nipro Medical Corporation participated in the 2013 Spring Clinical Meeting hosted by the National Kidney Foundation. The NKF Spring Clinical meeting brings together nephrology professionals involved in the treatment of kidney disease, from nephrologists to dietitians.
Nipro Medical Corporation is a world-leading manufacturer of renal, medical-surgical and interventional radiology products. They are committed to delivering innovative, high quality and value-added solutions to improve patient care. Nipro Medical generated $ 2.1 billion last year and has a team of over 10,000 employees in the US.